Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Nov 28, 2018 in Leukemia | 0 comments

In a nutshell

This study examined the effectiveness of vibration therapy on patients receiving chemotherapy for leukemia and lymphoma. Researchers found that vibration therapy improved daily function in these patients.

Some background

Exercise is proven to be effective in improving outcomes of patients with cancer. Chemotherapy treatment can make exercise difficult in these patients. Vibration therapy involves stimulating nerves and muscles in these patients. It is not yet known if this may benefit daily function in patients with leukemia and lymphoma treated with chemotherapy.

Methods & findings

20 patients with leukemia and lymphoma being treated with chemotherapy were included in the study. One group received vibration therapy. The other group did cycling exercises (control group). Changes in chemotherapy side effects, blood pressure, and heart rate were recorded. Some daily function tests were also measured. These included jump height and time of chair-rising (CRT). Timed up and go (TUG; a test of a person's mobility and balance) was also measured. 

No changes in blood pressure or side effects were seen between the groups. No worsening in chemotherapy side effects was seen in the vibration treatment group. Jump height in the vibration treatment group increased by 2.3cm. TUG was reduced by 1.3 seconds in the patients with vibration therapy. CRT did not change between groups.

The bottom line

The study concluded that vibration treatment was effective in improving mobility in patients with leukemia and lymphoma receiving chemotherapy.

The fine print

This was the first study of its kind and had a very small number of patients. More research is required to confirm these results.

Published By :

BMC cancer

Date :

Sep 25, 2018

Original Title :

Feasibility of whole body vibration during intensive chemotherapy in patients with hematological malignancies – a randomized controlled pilot study.

click here to get personalized updates